Skip to content

Cancer Genome Analysis

Cancer Genome Analysis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01458704
Enrollment
100
Registered
2011-10-25
Start date
2011-08-31
Completion date
Unknown
Last updated
2011-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Tumor

Brief summary

Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.

Interventions

OTHERnext generation sequencing

next generation sequencing (including targeted gene sequencing, exome sequencing, transcriptome sequenicing)

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with malignant tumor * receiving or planning to receive chemotherapy * with fresh frozen tumor tissue * with informed consent

Design outcomes

Primary

MeasureTime frameDescription
targeted sequencing of cancer-relate genes1 yearIdentification and characterization of genetic alteration in cancer tissue

Countries

South Korea

Contacts

Primary ContactTae-You Kim
82-2-2072-2228

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026